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Abstract 21 
Histoplasma capsulatum var. farciminosum (HCF), the causative agent of epizootic lymphangitis 22 
(EZL), is endemic in parts of Africa. Diagnosis based on clinical signs and microscopy lacks 23 
specificity, and is a barrier to further understanding this neglected disease. Here, a nested PCR 24 
method targeting the ITS region of the rRNA operon was validated for application to equine 25 
clinical samples. Twenty-nine horses with signs of EZL, from different climatic regions of 26 
Ethiopia, were clinically examined. Blood samples and aspirates of pus from cutaneous nodules 27 
were taken, along with blood from a further 20 horses with no cutaneous EZL lesions. HCF was 28 
confirmed in DNA extracts of pus and blood samples from 25 and 17 horses, respectively, of the 29 
29 suspected EZL cases. Positive PCR results were also obtained from heat-inactivated pus (24 30 
horses) and blood (23 horses) spotted onto Whatman FTA cards. Two positives were obtained 31 
among blood samples from 20 horses that did not exhibit clinical signs of EZL. These are the 32 
first reports of the direct detection of HCF in equine blood, and at high frequency amongst 33 
horses exhibiting cutaneous lesions. The nested PCR outperformed conventional microscopic 34 
diagnosis, as characteristic yeast cells could only be observed in 14 pus samples. HCF DNA was 35 
confirmed by sequencing the cloned PCR products, and while alignment of the ITS amplicons 36 
showed very little sequence variation, there was preliminary SNP-based evidence for the 37 
existence of two subgroups of HCF. This molecular diagnostic method now permits 38 
investigation of the epidemiology of EZL. 39 
 40 
 41 
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Introduction 42 
Epizootic lymphangitis (EZL), caused by the dimorphic fungus Histoplasma capsulatum var. 43 
farciminosum (HCF), is traditionally a disease of equids; the related species H.capsulatum var. 44 
capsulatum causes histoplasmosis in humans and is an important opportunistic pathogen 45 
worldwide [1]. The clinical presentation in horses varies, with four forms described [2]: 46 
asymptomatic; ocular; cutaneous; respiratory. Mixed forms can occur [3]. The cutaneous form 47 
is characterized by multi-focal pyogranulomatous sub-cutaneous nodules that progress along 48 
the lymphatic system, with coalescence of nodules producing a ‘corded’ appearance. If lesions 49 
are located on the limbs, progression of the disease can result in severe lameness. The 50 
respiratory form is classically characterised by pyogranulomatous lesions within the nasal 51 
mucosa and lung parenchyma, with potential for multi-systemic pathology [2-7].  52 
Although eradicated from Europe, EZL is currently prevalent in Ethiopia where, dependent upon 53 
region, between 0% and 39% of equids may be infected [8, 9, and 10]. Ethiopia has Africa’s 54 
largest equine population, where approximately 2 million horses have a crucial role in the 55 
economy of both urban and rural communities [11-13]. In two separate participatory studies in 56 
different areas of Ethiopia [14, 15], horse owners consistently volunteered EZL as a high priority 57 
disease. EZL contributes to extensive morbidity and subsequent mortality due to abandonment 58 
of chronically infected animals, and can have a devastating impact on the income of poor 59 
families [16, 17].  60 
 61 
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Within disease endemic regions, access to treatment is a significant challenge. SPANA (Society 62 
for the Protection of Animals Abroad) currently provides free veterinary care within their 63 
clinics, however topical treatment with tincture of iodine and oral dosing with potassium 64 
iodides, is labour intensive, expensive and of limited efficacy in moderate to severe cases of EZL 65 
[18]. It is imperative that animals are diagnosed early in the course of the disease to improve 66 
treatment outcomes, conserve resources and reduce the burden of infection within the 67 
population. Currently, due to limited available diagnostic technology, veterinarians in Ethiopia 68 
diagnose the disease based on clinical appearance and microscopic examination for yeast cells 69 
within pus. This has the potential for misdiagnosis as the clinical appearance can mimic other 70 
diseases (e.g. ulcerative lymphangitis, sporotrichosis and the cutaneous form of glanders [2, 9, 71 
19, 20]). Culture of HCF from clinical lesions would be definitive, but is challenging and rarely 72 
attempted. Therefore, reliable and robust approaches to diagnosis are required to support 73 
clinical decision making and enable epidemiological studies to provide the rationale for the 74 
development of disease prevention strategies. EZL has recently been highlighted as a priority 75 
neglected disease of working equids [21]. 76 
Classically, members of the genus Histoplasma have been classified into three separate 77 
varieties, capsulatum (HCC), duboisii and farciminosum (HCF) defined by host species and 78 
pathogenesis [22]. However, Histoplasma spp. have more recently been grouped into eight 79 
clades based upon MLST of isolates combined with geo-spatial distribution of their sources [23]. 80 
HCF has long been considered an equine specific pathogen, but the application of molecular 81 
biology techniques has identified a broader host and geographic range for HCF with clinical 82 
cases reported in dogs [24], badgers [25] and even humans [26].  The phylogeny of Histoplasma 83 
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spp. has been examined using a range of different gene loci [23, 24, 26-31].  As has been 84 
frequently reported for fungi, sequence variation in the ITS region of the ribosomal RNA operon 85 
provides sufficient resolving power to discriminate between closely related species and 86 
variants, and can contribute to the design of specific PCR-based detection protocols [26, 28, 32, 87 
33]. For HCF, a nested PCR protocol for specific identification of cultures has been designed [32] 88 
and is adapted here for use with clinical material. Isolates and/or sequences of both equine and 89 
human origin from Africa are under-represented in studies on the phylogeny of histoplasmas 90 
[26, 27, 30, 34-36], which is at odds with their prevalence in these regions [37-40]. Phylogenetic 91 
analysis of a handful of historic cultures from equine clinical cases has been described [26, 28], 92 
but no studies have reported the application of PCR to diagnose HCF directly in clinical 93 
specimens.  94 
This study has two primary objectives: 1) to establish and validate the use of DNA extraction 95 
and PCR amplification protocols to rapidly identify HCF directly from equine clinical specimens, 96 
and stored clinical samples and 2) to generate ITS region sequences that may provide an insight 97 
into strain diversity. 98 
 99 
 100 
 101 
 102 
 103 
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Methods 104 
The methods for extracting DNA from equine pus were optimised prior to field sampling as 105 
follows. DNA extraction was tested on pus samples collected from horses in the UK (incisional 106 
site infection and sinusitis samples collected at surgery) and pus samples spiked with a 1/10 107 
(v/v) cell culture suspension of Saccharomyces cerevisiae as a proxy for HCF in order to 108 
demonstrate that fungal DNA could be recovered from pus. DNA preparations were obtained 109 
using the Qiagen blood and tissue kit according to manufacturers’ instructions but using a 110 
starting volume of 50µl of pus and extending the incubation at 560C to 2-3 hours to ensure 111 
adequate lysis of the sample. The DNA yield was assessed by Nanodrop followed by running the 112 
genomic DNA extract on a 2% agarose gel stained with Midori green.  113 
 114 
Case selection and sampling 115 
Field sampling of clinical cases presented to the SPANA mobile veterinary clinical team was 116 
undertaken in Ethiopia between February and April 2014. Cases were selected from each of 7 117 
SPANA clinic sites on the basis of clinical signs suggestive of infection with HCF provided that 118 
they presented palpably fluctuant and unruptured nodules.  Sampling regions varied by 119 
altitude, topography and climate (Table S1). Verbal informed consent was sought from all 120 
participating owners, and the study was approved by the University of Liverpool Research 121 
Ethics Committee and the Addis Ababa University, College of Veterinary Medicine and 122 
Agriculture’s ethics board prior to commencement. The horses of all owners attending SPANA 123 
clinics received free treatment regardless of their decision to volunteer for the study.  124 
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A 10ml jugular blood sample was taken from each case into EDTA and plain Vacutainer tubes. 125 
The area surrounding two unruptured cutaneous nodules was shaved, aseptically prepared, and 126 
the contents aspirated with a ½ inch 16 gauge needle. Aspirates were immediately transferred 127 
into separate sterile Eppendorf tubes and stored in a cool box prior to transfer to a refrigerator, 128 
and were processed within 24 h. Horses with respiratory signs were sampled using a nasal swab 129 
inserted into the rostral 10cm of the nasal mucosa. The swabs were placed directly into a 130 
universal bottle containing 20ml sterile saline. Where necessary, horses were sedated to 131 
facilitate sampling and allow subsequent treatment.  132 
Blood samples were collected from a further 20 horses from 5 highland regions where little or 133 
no EZL had previously been reported (4 horses from each region, Table S1). These horses did 134 
not have any cutaneous lesions suggestive of EZL and were randomly selected for comparison 135 
from a larger cohort of 350 horses being sampled for the presence of respiratory pathogens.  136 
Alongside the clinical sampling and treatment, a short questionnaire was delivered to owners to 137 
gather information on the clinical presentation, history of infection, and any previous 138 
treatment. The signalment, case presentation and clinical examination findings (performed by a 139 
veterinary surgeon/animal health professional) were recorded and lesion location recorded on 140 
equine silhouettes (Fig. 1). Suspected EZL cases were categorized as mild, moderate or severe 141 
based on a previously developed grading system [18] (Table S2).  142 
Sample processing in Ethiopia 143 
Slide preparations of pus, blood and nasal swab impression smears were stained with Giemsa 144 
using a 1:20 working solution [41]. The pus samples were examined for the presence of yeast 145 
cells suggestive of Histoplasma infection [42] at x1000 magnification under oil immersion. 146 
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Differential blood cell counts were calculated [43], the haematocrit (PCV) measured with 147 
capillary tubes, and the total protein measured with a hand-held refractometer [44]. 148 
Genomic DNA preparations from pus and blood were made using a Qiagen DNeasy Blood and 149 
Tissue kit in the clinical laboratory at SPANA, Debre Zeit, Ethiopia. Blood and 50µl pus samples 150 
were processed according to the manufacturer’s protocol. For the lysis step, the pus samples 151 
were heated in a water bath at 56oC for 2-3 hours, until the lysate appeared clear. The eluted 152 
DNA preparations were dried by evaporation from the Eppendorf tubes at 40oC. Eighty DNA 153 
extractions from blood and pus samples were transported to the University of Liverpool under 154 
UK (DEFRA) approved licensing. 155 
FTA card preparation 156 
To examine the use of Whatman FTA cards as a convenient method to capture, transport and 157 
store DNA, pus and blood samples from case horses were placed onto classic Whatman FTA 158 
indicating cards (GE Healthcare). Aliquots (0.5ml) of pus diluted with 0.5ml of sterile saline were 159 
inactivated by heat treatment at 95oC for 30 min in a water bath prior to applying 200µl of 160 
sample to the card [45]. Two 200µl blood spots and two heat-inactivated pus samples from 161 
each horse were placed onto separate sample zones and the loaded FTA cards were air dried 162 
overnight before being microwaved at full power (800 Watt) for 30 s, left to stand for one min, 163 
and microwaved for a further 30 s. A glass beaker containing >200ml of water was placed 164 
alongside cards in the microwave to dissipate heat. Heat inactivated cards were individually 165 
placed into sealable plastic bags and despatched to the University of Liverpool where they were 166 
stored at 4oC upon arrival. 167 
  168 
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Validation of a nested-PCR protocol for detecting HCF in DNA preparations 169 
DNA preparations from HCF reference strain CBS 539.84 and HCC reference strain CBS 137.72 170 
were obtained from CBS-KNAW Fungal Biodiversity Centre, Netherlands and used as positive 171 
controls. DNA extracts of Saccharomyces cerevisiae, Escherichia coli and pus collected at 172 
surgery from a horse in the UK were used as negative controls. 173 
Precipitated DNA samples (Qiagen) were rehydrated with DNA and RNA-free water, and 174 
analysed by Nanodrop. Aliquots of 50ngµl-1 DNA were prepared and stored at -20oC before use. 175 
A nested PCR protocol targeting the ITS region coding for rRNA genes was adapted from that 176 
published by Jiang et al. 2000 [32]. Both sets of primers (P3 / 2R8 and F5 / 2R5) spanned the 177 
ITS1-5.8S-ITS2 region [32]. The optimum annealing temperatures for each primer pair were 178 
determined with control HCF template DNA. Each reaction mixture contained 50ngµl-1 of 179 
template DNA and 10pmol concentrations of PCR primers P3 and 2R8 added to Biomix red 180 
(Bioline) in a 25µl volume reaction as follows: 12µl Biomix red; 2µl forward and 2µl reverse 181 
primer; 8µl H2O; 1µl DNA template. The first round PCR using P3/2R8 primers (P3 5’-182 
CGGAAGGATCATTACCACGCCG-3’, 2R8  5’-CAGCGGGTATCCCTACCTGATC-3’) was performed on 183 
the following thermocycler programme; 94oC for 10 min (denaturation), then 35 cycles of 94oC 184 
for 1min, 49oC for 1min then 72oC for 1min followed by a final extension cycle of 72oC for 185 
10min. The product for the 1st round was expected to be 587bp and this was visualised by 186 
electrophoresis on a 2% agarose gel stained with Midori green compared to a 1kb hyperladder 187 
(Bioline). A 1 in 10 (v/v) dilution of product from this first reaction was added to fresh master 188 
mix including 10pmol concentrations of primers F5 and 2R5 (F5 5’-189 
CTACCCGGCCACCCTTGTCTAC-3’, 2R5 5’-CCTACCTGATCCAGTCAACC-3’). The thermocycler 190 
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programme for the second round was the same except the annealing temperature was raised 191 
to 55oC for 1 min. The expected product was 514bp and was visualised on a 2% (w/v) agarose 192 
gel stained with Midori green (2µl per 100ml agarose) via electrophoresis at 70V for 30 193 
minutes. Excess primers and nucleotides were removed from PCR amplicons using ExoSAP-IT 194 
(USB products) and the forward sequence determined (GATC Biotech).  195 
DNA extraction from pus and blood samples on Whatman FTA cards  196 
The FTA cards were prepared for analysis using a hole punch (Knippex 9070220, Germany). The 197 
following protocol produced the most satisfactory DNA yield from both blood and pus samples 198 
on Whatman FTA cards and was applied throughout. For each pus and blood sample spot, 4 x 199 
5mm hole punches were produced. Between samples, the hole punch was sterilised by 200 
immersion in 100% ethanol followed by flaming. The FTA punches were placed into a screw cap 201 
tube containing 0.5g acid washed glass beads (425-600µm diameter), 0.5 ml H2O and 0.5 ml 202 
Phenol Chloroform Isoamyl alcohol (25:24:1 pH8). The solution was mechanically disrupted 203 
using a Powerlyser homogeniser at 2100 rpm for 5 min and then centrifuged at 8000xg for 3 204 
min. The uppermost aqueous phase was extracted into a sterile tube and 0.5 ml chloroform 205 
added. The mixture was centrifuged at 8000xg for 3 min and the aqueous phase was again 206 
collected. DNA was precipitated by adding 1 ml of ethanol and 5µl of 200mM sodium acetate 207 
and incubating the mixture at -20oC for > 2h. The ethanol precipitate was microcentrifuged at 208 
13,000xg for 10 min and the supernatant removed and discarded. The DNA pellet was air dried 209 
then reconstituted in 50µl sterile DNA and RNA free H2O. The resulting DNA preparation was 210 
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analysed using a Nanodrop prior to being tested for the presence of HCF DNA by nested PCR as 211 
described above.  212 
Cloning PCR products  213 
A sub-sample of 9 Histoplasma positive amplification products of the second round of the 214 
nested PCR were cloned in E.coli [46]. DNA bands of the expected size from the second round 215 
of the nested PCR were excised and extracted using Bioline PCR and Gel Kit (Bioline). 2 µL of 216 
each of the DNA preparations were mixed with 5 µl ligation buffer (60mM Tris-HCl [pH 7.8], 217 
20mM MgCl2, 20mM DTT, 2mM ATP, 10% PEG), 1 µl pGEM-T Easy plasmid vector containing an 218 
ampicillin resistant gene (Promega), 1 µl T4 DNA Ligase preparation and made up to 10 µl with 219 
deionised water. This reaction was then left overnight at 4°C and 4 µl of the ligation reaction 220 
mixture was then added into 100 µl aliquots of thawed Top10 Escherichia coli competent cells 221 
and placed on ice for 20 min. The cells were subsequently heat shocked at 42°C for 45-50 s, 222 
returned to ice for a further 2 min and  950 µl of LB then added to each aliquot before 223 
incubation at 37°C with shaking for 1.5 h. 100 µl of cell suspension were then pipetted onto LB 224 
agar plates containing 100 µgml-1 Ampicillin, 100 µl of IPTG (100 mM), and 20 µl of X-Gal (50 225 
mg/ml) for blue/white screening. White colonies (containing inserts) were then picked and each 226 
inoculated into 10 ml LB plus 100 µgml-1 Ampicillin, and incubated for 16-24 h at 37oC. Five 227 
colonies from each of the 9 samples were randomly selected, and the plasmids then purified 228 
from the E. coli cultures (Plasmid Mini Kit – Isolation of High-Copy plasmid DNA, Bioline) and 229 
the presence of the target DNA in the plasmid confirmed by amplification with the primer pair 230 
F5/2R5 used above. Each plasmid DNA preparation was then sequenced (GATC Biotech AG). All 231 
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sequence data were analysed using BLAST search engine 232 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The cloned sequence data were edited to remove any 233 
plasmid DNA, leaving fragments of ca. 514 nucleotides in length encoding the 18S rRNA internal 234 
transcribed spacer regions. These fragments were then aligned using ClustalW2 software. 235 
Screening for Corynebacterium species by multiplex PCR. 236 
As Corynebacterium pseudotuberculosis (causing ulcerative lymphangitis) is one of the 237 
differential diagnoses for the cutaneous presentation of EZL [2, 9], all 80 DNA extracts from pus 238 
and blood samples were screened by multiplex PCR for the presence of Corynebacterium spp. A 239 
freeze dried culture of Corynebacterium pseudotuberculosis (DSMZ No. 20689) was obtained 240 
from the Liebniz institute DSMZ (www.dsmz.de/), cultured in brain heart infusion media with 241 
glucose (5mgml-1), and incubated at 37oC with agitation. DNA was extracted [47] and a 242 
multiplex PCR was used to amplify the 16S rRNA gene (816 bp), rpoB (encoding the RNA 243 
polymerase β-subunit) (446 bp) and pld (encoding an exotoxin) (203 bp) present in the genome 244 
of C. pseudotuberculosis using the six oligonucleotide primers described in Pacheco et al. [48]. 245 
The amplification products were visualised on a 1% (w/v) agarose gel stained with Midori green. 246 
Statistical analyses 247 
Descriptive statistics of the clinical examination data were produced and comparisons made 248 
between case and control horses using SPSS software, with the cut-off for statistical significance 249 
set at p<0.05. The different diagnostic methods (nested PCR, microscopy and pattern 250 
recognition of clinical signs) were compared using diagnostic test comparison tables [49]. 251 
Univariable logistic regression analysis was used to compare clinical signs.  252 
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 253 
 254 
 255 
 256 
Results 257 
In total, 29 case horses with suspected EZL and 20 horses, selected as comparisons from 258 
highland regions (>2,300 msl) in Ethiopia where EZL has not previously been reported, 259 
comprised the study. This included 28 geldings, 18 stallions, 1 mare and 2 unrecorded. 260 
Supplementary Table S3, summarises the questionnaire and clinical examination findings for all 261 
case and control horses. Among the 29 presumptive EZL cases, 11 (38%) were classified as early, 262 
12 (41%) as moderate and 6 (21%) as severely affected cases (Table S2 and Fig. 1).  263 
Three of the case horses had signs of lower respiratory disease: 1 categorised as mild EZL with 264 
lesions on the lateral neck and generally increased respiratory noise detected on thoracic 265 
auscultation; 1 categorised as moderate EZL and observed to be coughing with bilateral 266 
mucopurulent nasal discharge and retropharangeal lymph node swelling; 1 categorised as 267 
severe EZL with bilateral mucopurulent nasal discharge and ulceration apparent on the nasal 268 
mucosa. Nasal swabs were collected from the latter 2 horses and tested positive for HCF by the 269 
nested PCR diagnostic method reported here. A further seven of the case horses presented 270 
with a range of mild upper respiratory signs. 271 
 272 
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Five of the case horses showed varying degrees of lameness, and 9 had ocular abnormalities 273 
present. No typical ocular signs of EZL lesions were seen among these cases, as has been 274 
indicated previously [2, 3]. EZL case horses tended to demonstrate eosinopaenia and 275 
monocytosis in comparison to controls (Table S3, p<0.05), which is consistent with a chronic 276 
pyogranulomatous infection.  277 
Diagnostic tests 278 
Of the 29 case horses, impression smears were prepared from a total of 27 pus and 28 blood 279 
samples (in 2 horses with cutaneous lesions it was not possible to aspirate nodules, and for 1 280 
horse only a pus sample was taken). Yeast cells were apparent in 14 (52%) pus smear 281 
preparations as determined by light microscopy (Fig. 2). No yeast cells were visible on any of 282 
the blood smear preparations. 283 
A total of 80 Qiagen DNA extractions were made from blood, pus and nasal swabs from 29 case 284 
horses (duplicate extractions were prepared for the majority). The overall DNA yield varied 285 
between samples, with a median of 68 ngµl-1 and A260/A280 ratio of 1.8. The DNA yields from the 286 
FTA card samples processed by the phenol chloroform extraction method had a median yield of 287 
57 ngµl-1, A260/A280 ratio 1.2. 288 
Samples were scored positive if the nested PCR protocol produced 514bp amplicons, as 289 
visualised by agar gel electrophoresis. In all cases, nested PCR was found to be necessary, and 290 
amplification products could not be reliably detected after the initial round of amplification 291 
with the P3/2R8 primer pair. Similarly, primary amplification with the F5/2R5 primer pair did 292 
not yield products, nor did two rounds of amplification with these primers. Control DNA from H 293 
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capsulatum var. capsulatum and var. farciminosum cultures could be amplified with the 294 
individual primer pairs when used directly, but this was not nearly as reliable as the nested PCR 295 
protocol. The detection limits of the nested PCR were tested using serial dilutions of HCC 296 
control DNA template. At a 1/100 dilution, it was still possible to detect 0.5ng HCC DNA using 297 
this nested PCR.  298 
In total, 25 of the 27 EZL case horses tested positive based on analysis of Qiagen DNA extracts 299 
from pus, and 17 of the 27 (63%) case horses from blood samples; examples are presented in 300 
Fig. 3. Of the FTA card samples, 24 of the 27 pus samples and 23 of the 28 blood samples were 301 
positive for HCF as determined by the nested PCR protocol. This all compares very favourably 302 
with the low levels of detection of yeast cells (52%) in pus samples taken from these EZL horses.  303 
The forward sequence determination for all nested PCR amplification products confirmed their 304 
identity as histoplasmas (>97% similarity by BLAST analysis; data not shown). Of the FTA card 305 
blood samples from the 20 control horses (originating from outside of areas where EZL is 306 
endemic, and showing no signs of disease), two positives were obtained by nested PCR (Table 307 
S4). Sequencing also confirmed that these amplicons were from Histoplasma DNA. While the 308 
PCR results obtained from the Qiagen extracts were reproducible for each of the 10 horses 309 
repeated, the PCR results were not reproducible for all of the pus and blood spots presented on 310 
FTA cards (Table S4); 4 of the 27 pus samples, and 9 of the 28 blood samples, gave positive 311 
results that were not completely reproducible.  Therefore, for the purposes of data analysis, we 312 
identified a horse as positive for histoplasmosis if at least one of the pus samples or at least one 313 
of the blood samples were positive for HCF on nested PCR.  314 
 o
n
 O
ctober 6, 2016 by University of Liverpool Library
http://jcm.asm.org/
D
ow
nloaded from
 
16 
 
In addition to simple sequencing of potentially mixed PCR amplification products to confirm the 315 
identity of amplicons as Histoplasma, we cloned 15 of  these to produce a total of 43 clone 316 
sequences of the amplified ITS region for more detailed phylogenetic analysis. Bona fide 317 
sequence data were obtained for 38 full length 514 bp amplicons, and these were aligned (Fig. 318 
S1).   319 
Across the entire 514bp fragment of the ITS region sequenced here, there were nine consistent 320 
single nucleotide polymorphisms (representing a 1.8% substitution rate) that divided the 38 321 
clone sequences into two coherent subgroups.  These are: position 83, TC; 249, TC; 328, GC; 322 
342, AG; 366, AC; 439, AG; 3 sequential nucleotide substitutions at positions 449-451, CGT in 323 
place of GTC. The alignment of these two subgroups and the comparable sequences of H. 324 
capsaulatum var. capsulatum and var. farciminosum are presented in Fig. 4. Representatives of 325 
each subgroup did occasionally originate from a single horse sample, and analysis of the 326 
contextual metadata did not reveal any patterns in origin of sample or stage of disease.  327 
Microscopy generally had a lower sensitivity and specificity compared to PCR for both Qiagen 328 
and FTA card extracts (Table 1a). In all cases where yeast cells were visible on microscopy, the 329 
PCR test was positive on pus samples, except in one instance among the FTA card results. Yeast 330 
cells were never observed microscopically in blood samples, however HCF was detected by 331 
nested PCR in many of these samples (16 positive among Qiagen extracts and 21 among FTA 332 
card samples; Table 1a and S4). Among this case series, if clinical sign were apparent  there was  333 
>80% probability that the diagnosis would  be confirmed by PCR of blood samples (Table 1b). 334 
None of the 80 Qiagen DNA extracts from blood and pus samples tested positive for 335 
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Corynebacterium spp. with the multiplex PCR diagnostic test [48] applied here, validated by the 336 
inclusion of appropriate positive and negative controls.  337 
 338 
 339 
 340 
Discussion 341 
The nested PCR primer sets developed by Jiang et al. [32] for Histoplasma capsulatum var 342 
capsulatum cultures were used here to develop a diagnostic test for HCF in clinical samples of 343 
horses. Two stage nested amplification was found to be necessary, and this may be due to the 344 
biological diversity within the clinical samples that contained a variety of equine DNA including 345 
immune cells and degradation factors, and potentially low numbers of yeast cells. This is 346 
comparable to other scenarios where nested PCR reactions are required to detect fungal 347 
targets in complex clinical samples [50]. Diagnostic reliability of the nested PCR protocol was 348 
much superior to conventional microscopy or sole reliance on clinical signs. In all cases, 349 
sequencing of the 514bp amplicons demonstrated the presence of Histoplasma DNA, and this 350 
was further confirmed by sequencing a large sample of clones. PCR methods targeting the ITS 351 
region have previously been used to identify HCC [28, 30] and have the additional advantage of 352 
enabling strain sequence variation to be explored [32]. In that respect, we also identified a 353 
collection of single nucleotide polymorphisms (SNP’s) that suggest a delineation of at least two 354 
sub-groups of HCF circulating in the working horse population in Ethiopia. At this early stage, 355 
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there is no evidence that the occurrence and distribution of these two sub-groups correlates 356 
with clinical signs and severity of disease, geographical location, sample source, or any other 357 
identifiable parameter. In fact, both sequence variants were recovered from the same animal 358 
on a few occasions. Alignment of HCF and HCC ITS region sequences shows a high degree of 359 
conservation, in agreement with the minimal diversity that was reported among Histoplasma 360 
spp. in the ISHAM ITS barcoding project [33], so it may be more appropriate to target 361 
alternative genetic loci in histoplasmas in any search for markers of variation that may have 362 
epidemiological utility. Previous molecular taxonomic studies have identified a close link 363 
between HCC and HCF [26, 27] and therefore characterising strains from currently endemic 364 
regions is appropriate. There are many unanswered questions, eg. can HCF be zoonotic, is there 365 
any strain variation that impacts on virulence and clinical presentation, is there host specificity, 366 
what are the modes of transmission, are  vectors involved and what is the epidemiology of EZL? 367 
The biological relationship and functional difference between HCC, a relatively well studied and 368 
principally human pathogen, and HCF, primarily a specific pathogen of equids, is unknown. 369 
Representative strains of Histoplasma spp. (including HCC and HCF) from endemic regions on 370 
the African continent are especially lacking, and this is a public health blind spot considering the 371 
high burden of infection [37-40].  372 
Another important aspect of this study is the demonstration that the nested PCR assay can be 373 
used to detect HCF in inactivated pus and blood samples dried onto Whatman FTA cards.  These 374 
cards have been used extensively to archive a range of human, animal, plant, bacterial, fungal 375 
and viral pathogens, and are a convenient and cost effective method to store DNA and RNA for 376 
downstream molecular applications without the need for specialist equipment [45, 51, 52]. 377 
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Here, the advantages of Whatman FTA cards for sampling in the field, for inactivating 378 
pathogens, and for transporting and storing samples of equine pus and blood for application of 379 
molecular diagnostic methods are obvious. They are very suitable for use in countries with 380 
limited resources but ideally we would hope to simplify the DNA extraction protocol, especially 381 
finding an alternative to phenol chloroform treatment, which was used because it was found to 382 
be very effective compared to a number of other methods tested. The stability of DNA in 383 
equine pus and blood samples stored on FTA cards also needs to be established; previous 384 
studies have identified issues concerning storage and sample longevity [53].  385 
This is the first report of PCR based detection of HCF directly in equine blood. PCR detection of 386 
Histoplasma spp. directly from human blood samples has been reported previously [54-56] and 387 
a fungaemic stage is recognised in human infection [57, 58]. Our data suggest the identification 388 
of HCF fungaemia in horses, although further work is required to determine the timing of the 389 
development of fungaemia, and investigate the potential for early diagnosis of HCF directly 390 
from blood samples. Furthermore, our identification of HCF DNA in two blood samples from 391 
horses with no clinical signs of EZL, could be due to subclinical infection and/or asymptomatic 392 
carriage, both aspects of EZL about which there is currently no information.   393 
Ideally, horses in Ethiopia and other countries where EZL has been reported, should not be 394 
diagnosed solely on the basis of clinical signs. There are a number of other pathogens causing 395 
infections which have similar clinical presentations. Although we were able to exclude 396 
ulcerative lymphangitis by demonstrating that all 29 horses were PCR positive for HCF and 397 
simultaneously negative for Corynebacterium  spp., we did not address Sporotrichosis [59] and 398 
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the cutaneous (farcy) form of glanders [20] both of which can easily be confused with EZL. Sero-399 
conversion in response to glanders exposure has recently been reported among donkeys within 400 
similar regions of Ethiopia [60], which further emphasises the importance of establishing the 401 
causative agent of disease in individual horses that present with ulcerative and 402 
pyogranulomatous lesions. 403 
Histoplasmosis is not only a problem among horses, but also human populations, where HCC 404 
has been recognised as a severely underdiagnosed chronic disease [38, 61-64]. Among a large 405 
case-series in people, it was reported that a spectrum of presenting clinical signs could be 406 
associated with histoplasmosis and this had implications for delays in clinical recognition, 407 
requests for suitable diagnostic tests and the initiation of trial treatment, and ultimately, case 408 
outcome [65]. Likewise, Lesion location (Fig.1) and clinical presentation of EZL varied widely 409 
among the equine cases presented here, and HCF was also identified in DNA extracts from nasal 410 
swab samples from two of the most severe cases with respiratory signs. The well characterised 411 
human variant, HCC, is predominantly a respiratory pathogen [37] whereas, the role of HCF as a 412 
respiratory pathogen in horses is largely unknown [2, 4, 7, 66].  413 
A recent workshop on infectious disease of working equids called for ‘increased research to 414 
address technical data gaps, advocacy to secure funding, and improved surveillance at national 415 
and international level to allow further understanding of pathogenesis, diagnosis, treatment 416 
and prevention of disease such as Epizootic lymphangitis’ [21].  Robust, reliable and rapid 417 
diagnostic tools are essential for both decision making by veterinarians and to enable large-418 
scale studies that will allow further understanding of the epidemiology, ecology and 419 
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transmission of this neglected disease. Ideally, rapid diagnostic techniques could be beneficially 420 
utilised within endemic regions and therefore, future work should focus upon examining the 421 
practicalities and potential for transfer of technology to regional laboratories,  academics and 422 
clinicians within Ethiopia, and other regions. Resources to perform PCR are currently available 423 
in only some research laboratories within Ethiopia, where diagnostics could be further 424 
developed. A WHO report investigating research facilities in national health research systems in 425 
sub-Saharan Africa stated that ‘major constraints are dominated by financial input for 426 
equipment purchase, maintenance and laboratory supplies’ [67]. These factors need to be 427 
addressed in order to support and action future research development within disease endemic 428 
regions.  429 
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Tables and Figures 654 
Table 1a: Comparing microscopic visualisation of yeast cells in pus with nested PCR detection using DNA extracts (from Qiagen and FTA card 655 
preparations) of pus and blood from horses suspected of clinical infection with epizootic lymphangitis. 656 
 PCR result from Qiagen 
extracts from pus* 
PCR result from Qiagen extracts 
from blood* 
PCR result from FTA card 
preparation of pus* 
PCR result from FTA card 
preparation of blood spot* 
 Positive Negative Positive Negative Positive Negative Positive Negative
Yeast cells Present in 
pus on microscopy  14 0 7 7 12 1 11 3 
Yeast cells Absent in 
pus on microscopy 11 2 9 2 12 1 10 2 
Total  25 2 16 9 24 2 21 5
 Comparison of microscopy 
with PCR Qiagen pus extracts 
Comparison of microscopy with 
PCR Qiagen blood extracts 
Comparison of microscopy with 
PCR from pus on FTA cards 
Comparison of microscopy with 
PCR from blood on FTA cards 
Sensitivity1 0.56 0.44 0.5 0.52
Specificity2 1 0.22 0.5 0.4
PPV3 1 0.5 0.92 0.79 
NPV4 0.15 0.18 0.08 0.17
 657 
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Table 1b: Comparing diagnosis based on the presence or absence of clinical signs of EZL with results of 659 
nested PCR (using FTA card blood spots from 48 horses including 28 with clinical signs of EZL and 20 with 660 
no clinical signs). 661 
 PCR result from blood on FTA cards* 
Presumptive EZL based 
on clinical signs 
Positive Negative 
Yes 23 5 
No 2 18 
Total 25 23 
Comparing performance of diagnosing based on clinical 
signs compared with PCR 
Sensitivity1  
0.92 
Specificity2  
0.78 
PPV3  
0.82 
NPV4 0.9 
 662 
Footnotes for Tables 1a and 1b 663 
The nested PCR tests result is considered as the gold standard here because a known HCF control was used in the 664 
test. 665 
*PCR test results based on at least one positive PCR test per horse.  666 
NB no blood was taken from 1 horse with clinical signs suspicious of EZL; one horse did not have a Qiagen DNA 667 
extract made from a blood sample. 668 
1 The sensitivity describes the proportion of microscopy positive samples that are correctly diagnosed compared 669 
with the PCR results. 670 
2 The specificity describes the proportion of microscopy negative samples that are correctly diagnosed compared 671 
with the PCR results. 672 
3 PPV positive predictive value of microscopy compared to PCR, or the probability of a positive result on 673 
microscopy given that the test is positive by PCR.  674 
4 NPV negative predictive value of microscopy compared to PCR, or the probability of a negative result on 675 
microscopy given that the PCR result is negative. 676 
 677 
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Figure Legends 678 
Figure 1: Cutaneous EZL lesions observed in the infected horses. A) Mild case – lesions evident 679 
in only one body area; B) Moderate case - lesions distributed over left forelimb and other body 680 
sites, and moderate cording on forelimb; C) Severe case – multiple coalescent nodules over all 681 
four limbs and extensive lesions on the face; D) Spatial distribution of cutaneous lesions of EZL 682 
across 29 horses with cutaneous lesions suspected to be EZL, plotted onto silhouettes using 683 
Webplot digitizer and R software. The plot demonstrates that cutaneous lesions were more 684 
densely distributed around the forelimbs, neck, chest and girth regions. 685 
Figure 2: Light micrograph of a pus impression smear from an EZL case horse stained with 686 
Giemsa and examined for the presence of Histoplasma yeast cells. Impression smear of pus 687 
aspirated from unruptured subcutaneous nodule viewed at x1000 magnification. The arrows 688 
demonstrate clusters of ovoid to lemon shaped yeast cells, 4-5µm diameter with characteristic 689 
refractive cell wall. For comparison, an equine neutrophil is approximately 12-15µm in 690 
diameter. 691 
Figure 3: Gel electrophoresis of nested PCR amplification products obtained from DNA extracts 692 
of horse pus and blood samples. DNA preparations were amplified with P3/2R8 primers (first 693 
round) then diluted 1 in 10 and subjected to a second round of PCR amplification with F5/2R5 694 
PCR primers to generate ITS gene products (514bp) indicative of the presence of Histoplasma 695 
DNA. All amplification products were subsequently sequenced to confirm >97% identity and 696 
closest match to Histoplasma capsulatus ITS region DNA.  Lanes 1-4 negative controls, DNA 697 
extracts from S.cerevisiae, E.coli, equine pus from UK and DNA and RNA free water; Lane 5, HCC 698 
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control DNA; Lane 6, HCF control DNA; Lanes 7 -25, PCR amplicons of Qiagen DNA extracts of 699 
blood and pus from horses with suspected EZL (lanes 7-23 DNA extracts from pus, lanes 24-26 700 
DNA extracts from blood, Lane 9 MW marker). 701 
Figure 4: Sequence alignment of 514 bp cloned fragments of the Histoplasma ITS region. The 702 
diagram illustrates the 9 consistent SNP’s (arrowed) identified here that divide the HCF ITS 703 
clones (38 clones) into two sub-groups. Subgroup 1 comprised 23 of the clones, and subgroup 2 704 
the remaining 15. The numbers at the top of the figure are the nucleotide positions in the ITS. 705 
The two reference sequences of HCC (Ajellomyces capsulatus) and HCF were downloaded from 706 
Genbank. 707 
 708 
 709 
 710 
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